8-K: Edgewell Personal Care Reports Strong Q4 FY26 Results, Guides FY27 Growth

Edgewell Personal Care announced robust fourth quarter and fiscal year 2026 results, showcasing significant adjusted EPS growth and providing a positive outlook for fiscal year 2027.

Summary

• Edgewell Personal Care reported a 3.0% increase in fourth quarter net sales to $484.1 million and a 1.8% increase for the full fiscal year to $1,996.5 million.
• Organic net sales grew by 3.1% in the fourth quarter and 0.3% for the full year.
• GAAP Diluted EPS was $0.23 for the quarter and $(0.05) for the full year.
• Adjusted EPS significantly increased to $0.78 for the quarter (up 50.0%) and $1.93 for the full year (up 6.6%).
• The company ended the quarter with $375.6 million in cash and $418.8 million available under its revolving credit facility.
• A quarterly cash dividend of $0.15 per common share was declared.
• Fiscal year 2027 outlook includes expected growth in organic net sales (1.0%-3.0%), Adjusted EBITDA ($250-$270 million), and Adjusted EPS ($1.85-$2.15).

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, with strong adjusted EPS growth and a clear outlook for continued improvement, despite some GAAP losses and ongoing restructuring costs.

Positives

• Strong growth in adjusted EPS for both the fourth quarter ($0.78, +50.0%) and full year ($1.93, +6.6%).
• Positive organic net sales growth in the fourth quarter (3.1%) and continued growth in North America and International segments.
• Significant improvement in adjusted gross margin (45.7%) and adjusted operating income (10.6%) in the fourth quarter.
• Solid cash position with $375.6 million in cash on hand and substantial credit facility access.
• Positive fiscal year 2027 outlook projecting growth in organic net sales, Adjusted EBITDA, and Adjusted EPS.
• Increased investment in advertising and sales promotion (A&P) to support focus brands and growth priorities.
• Return of capital to shareholders through dividends totaling $6.9 million in Q4.

Negatives

• GAAP net loss from continuing operations for the full fiscal year of $(2.2) million, or $(0.05) per diluted share.
• GAAP Diluted EPS decreased to $0.23 in Q4 2026 from $0.26 in Q4 2025.
• Full fiscal year 2026 gross margin decreased by 160 basis points compared to the prior year.
• Full fiscal year 2026 adjusted operating income decreased slightly to $161.6 million from $173.3 million.
• Significant restructuring and related costs of $101.8 million for the full fiscal year 2026.
• Higher SG&A expenses as a percentage of net sales for the full fiscal year 2026 (21.5% vs. 20.8%).

Risks

• Continued cost and competitive headwinds are expected.
• Potential for unfavorable currency movements impacting reported net sales.
• Risks associated with global financial factors, including tariffs, foreign currency fluctuations, and localized volatility.
• Disruption of business due to factors outside of control, such as natural disasters, conflicts, or disease outbreaks.
• Inability to design and execute a successful omnichannel strategy.
• Fluctuations in the price and supply of raw materials and costs of labor, warehousing, and transportation.
• Potential for impairment of goodwill and other intangible assets.
• Risks associated with international operations and managing third-party relationships.

Future Outlook

For fiscal year 2027, Edgewell expects organic net sales to increase by 1.0% to 3.0%, with an estimated 60-basis point negative impact from foreign currency changes. GAAP EPS is projected to be between $0.90 and $1.20, including restructuring costs. Adjusted EPS is forecasted to be in the range of $1.85 to $2.15. Adjusted operating margin is expected to increase by approximately 70 basis points, driven by gross margin expansion and lower SG&A, partially offset by higher A&P investment. Adjusted EBITDA is projected to be between $250 million and $270 million, and adjusted free cash flow is expected to be between $100 million and $120 million.

Management Comments

• "Fiscal 2026 was a year of meaningful progress and change for Edgewell, culminating in a strong fourth quarter that reflected continued growth in North America, a return to growth in International and stronger performance across our focus brands."
• "Our second-half performance enabled us to deliver the topand bottom-line outlook we established at the beginning of the year on an adjusted basis, providing further evidence that our investments in innovation, brand building and commercial execution are gaining traction."
• "We enter fiscal 2027 as a more focused business, with confidence in our plans to build on this progress, increase support behind our brands and improve profitability."
• "While significant cost and competitive headwinds persist, we believe the broader transformation of our operating model is creating greater capacity to invest and supporting more consistent growth and margin expansion."

Industry Context

StockSavvy.ai notes that Edgewell's performance, particularly the return to organic growth in the fourth quarter and positive outlook, aligns with a broader trend of consumer staples companies focusing on brand strength and efficiency to navigate inflationary pressures and evolving consumer preferences. The company's emphasis on innovation and brand building is a key strategy in the competitive personal care market.

Stakeholder Impact

• Shareholders: Continued dividend payments and a positive outlook for adjusted EPS growth may support shareholder value.
• Employees: Restructuring and transformation actions may impact workforce, but also aim to improve long-term operational efficiency.
• Suppliers: Increased investment in brands and potential operational efficiencies could lead to stable or increased demand.
• Creditors: The company maintains a solid cash position and access to credit facilities, supporting its debt obligations.

Next Steps

• Continue to invest in innovation, brand building, and commercial execution.
• Build on the progress made in fiscal 2026 to increase support behind brands and improve profitability.
• Implement restructuring and repositioning actions to strengthen the operating model, simplify the organization, and improve manufacturing and supply chain efficiency.
• Execute global transformation actions to deliver the new growth strategy and commercial ambitions.
• Continue to return capital to shareholders through dividends.
• Monitor and manage global financial risks, including currency fluctuations and inflation.

Key Dates

Recommendation

The company shows signs of a turnaround with strong adjusted EPS growth and a positive outlook, but the GAAP net loss for the full year and significant restructuring costs warrant a cautious approach. While the company is executing well on its adjusted metrics, the ongoing transformation and competitive headwinds suggest holding the stock to observe sustained GAAP profitability and margin expansion before considering a buy.

Keywords

personal care, shaving systems, sun care, skin care, consumer products, brand building, organic sales, adjusted EPS